Metformin Denk (Metformin Hydrochloride)

Metformin Denk is an oral antidiabetic that acts on glucose metabolism in type 2 diabetes and related insulin‑resistance conditions.

• Type 2 diabetes mellitus: improves glycemic control and reduces HbA1c levels.
• Prediabetes: helps delay progression to overt diabetes by enhancing insulin sensitivity.
• Polycystic ovary syndrome (PCOS): reduces insulin resistance and may improve menstrual regularity.

• Metformin reduces hepatic gluconeogenesis and increases peripheral glucose uptake by activating AMP‑activated protein kinase (AMPK). This leads to decreased hepatic glucose output, enhanced insulin‑mediated glucose utilization in muscle, and modest weight stabilization, collectively lowering blood glucose concentrations.

Metformin Denk may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

• Nausea: mild to moderate stomach upset.
• Diarrhea: loose stools, often early in therapy.
• Abdominal discomfort: cramping or bloating.
• Metallic taste: transient alteration of taste perception.
• Loss of appetite: reduced desire to eat.
• Flatulence: increased intestinal gas.

Serious or Rare Side Effects

• Lactic acidosis: rare but potentially fatal metabolic disturbance.
• Severe hypoglycemia: usually when combined with other glucose‑lowering agents.
• Vitamin B12 deficiency: may develop with long‑term use.
• Skin rash or hypersensitivity: including Stevens‑Johnson syndrome.
• Hepatic dysfunction: elevated liver enzymes.
• Pancreatitis: inflammation of the pancreas.

When prescribing Metformin Denk, clinicians should consider several safety factors.

• Renal impairment: avoid or dose‑adjust in patients with reduced kidney function.
• Hepatic disease: use with caution in patients with liver dysfunction.
• Alcohol consumption: limit intake to reduce risk of lactic acidosis.
• Iodinated contrast procedures: discontinue before and after imaging as advised.
• Elderly patients: monitor renal function and adjust dose if needed.
• Store at ambient temperature: keep below 25 °C, in original packaging, protected from moisture.

Metformin Denk can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid)

• Iodinated contrast media: may precipitate lactic acidosis.
• Cimetidine: can increase metformin plasma concentrations.
• Alcohol: potentiates risk of lactic acidosis.
• Other biguanides: additive risk of toxicity.
• Certain antivirals (e.g., didanosine): may increase adverse effects.

Moderate Interactions (Monitor Closely)

• Diuretics: may affect renal clearance of metformin.
• ACE inhibitors or ARBs: monitor renal function and potassium.
• Beta‑blockers: may mask hypoglycemia symptoms.
• Corticosteroids: can raise blood glucose, requiring dose adjustment.
• Oral contraceptives: may slightly increase metformin levels.